PARTNERSHIPS

Partnerships that advance precision therapeutics

SMDG works with pharmaceutical and biotechnology companies, academic and clinical researchers, patient organizations, foundations and strategic investors to discover and develop new medicines for complex diseases. Our collaborations bring together expertise in disease biology, biomarker discovery, therapeutic design, peptide engineering, nucleic acid therapeutics, nanomedicine, immune safety, data science and preclinical development. We welcome partnerships spanning discovery research, disease-focused programs, therapeutic co-development, licensing and translational development.

How We Partner

SMDG brings together its proprietary peptide platforms and multidisciplinary scientific capabilities to advance programs from early discovery through therapeutic development. We work flexibly with partners through research collaborations, co-development, licensing and strategic partnerships, aligning each relationship with the scientific and development needs of the program.

Why Partner with SMDG?

Four interconnected reasons to partner with SMDG: proprietary innovation, integrated expertise, flexible collaboration, and patient and disease focus.

Our Collaborative Network

SMDG has established an international network of collaborations spanning academic institutions, clinical research centers, biotechnology organizations and patient communities.

Discuss a partnership

PARTNERSHIPS

Partnerships that advance precision therapeutics​

How We Partner

Why Partner with SMDG?

Our Collaborative Network SMDG has established an international network of collaborations spanning academic institutions, clinical research centers, biotechnology organizations and patient communities.

Partnerships that advance precision therapeutics

Our Collaborative Network

SMDG has established an international network of collaborations spanning academic institutions, clinical research centers, biotechnology organizations and patient communities.